Vigabatrina no tratamento da síndrome de West: avaliação clínica e eletrencefalográfica em 13 pacientes

Henriques-Souza, Adélia Maria de Miranda; Ataide Junior, Luiz; Laurentino, Silvia Gomes.
Arq. neuropsiquiatr ; 65(1): 114-149, mar. 2007. tab
Artículo en Portugués | LILACS | ID: lil-446697

Documentos relacionados

  1. Fifteen years of real-world data on the use of vigabatrin in individuals with infantile epileptic spasms syndrome.
  2. Epileptic spasms related to neuronal differentiation factor 2 (NEUROD2) mutation respond to combined vigabatrin and high dose prednisolone therapy.
  3. Treatment with High-Dose Prednisolone in Vigabatrin-Refractory Infantile Spasms.
  4. Risk of vigabatrin-associated brain abnormalities on MRI: A retrospective and controlled study.
  5. Status of epileptic spasms: A study of 21 children.
  6. Epileptic spasms in CDKL5 deficiency disorder: Delayed treatment and poor response to first-line therapies.
  7. Response to sequential treatment with prednisolone and vigabatrin in infantile spasms.
  8. Treatment of Infantile Spasm Syndrome: Update from the Interdisciplinary Guideline Committee Coordinated by the German-Speaking Society of Neuropediatrics.
  9. Clinical profile, treatment modalities, and outcomes in patients with infantile spasms: A retrospective study from the United Arab of Emirates (UAE).
  10. The vigabatrin-associated brain abnormalities on MRI and their differential diagnosis.